| Liminatus Pharma, Inc. | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | Q1-CY2014 | Q4-CY2013 | |
| Balance Sheet Date | 2025-Jun-30 | 2025-Mar-31 | |||||||||||||||||||||||||||||||||||||||||||||||
| Fiscal Period | Q2-FY2025 | Q1-FY2025 | |||||||||||||||||||||||||||||||||||||||||||||||
| Close Price of Common Stock | 1.58$ | 1.65$ | 11.16$ | ||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap of Common Stock | 42,626,797$ | 42,924,144$ | 290,323,304$ | ||||||||||||||||||||||||||||||||||||||||||||||
| Close Price of Warrant | 0.14$ | 0.16$ | |||||||||||||||||||||||||||||||||||||||||||||||
| Close Price of Unit | |||||||||||||||||||||||||||||||||||||||||||||||||
| Close Price of Right | |||||||||||||||||||||||||||||||||||||||||||||||||